Oxidative stress, diseases and antioxidants

Agro Food Industry Hi-Tech

Volumn 17, Issue 4, 2006, Pages 6-9

  Milesi, Marie Anne ^a  

^a SEPPIC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT ENZYME; ELIMINATION RATE; NITROGEN SPECIES; NORMAL CONDITION; OXYGEN AND NITROGENS; PATHOLOGICAL CONDITIONS; PRIMARY ANTIOXIDANTS; REACTIVE SPECIES;

CELLS; CHAINS; CYTOLOGY; ENZYMES; FREE RADICALS; NITROGEN; OXIDATION; OXIDATIVE STRESS; OXYGEN; SUN;

ANTIOXIDANTS;

EID: 33749322704     PISSN: 17226996     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Chaudiere J., Some chemical and biochemical constraints of oxidative stress in living cell in : Free Radical Damage and its Control, CA Rice-Evans and RH Burdurdon Ed. Elsevier Science BV, 1994, 25-65.
2. Kherer JP., Smith CV., Free radicals in biology : sources, reactivities and roles in the etiology of human diseases in : Natural antioxidants in human health and diseases, B Frei Ed., 1994, 52-62.
3. Patel R. P., McAndrew J., Sellak H., White CR., Jo H., Freeman BA., and Darley-Usmar VM., Biological aspects of reactive nitrogen species. Biochim. Biophys.Acta 1411, 385-400 (1999).
4. Crow JP., Beckman JS., Reactions between nitric oxide, Superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv. Pharmacol. 34, 17-43 (1995).
5. Jiang Y., et al. Retrovirus-induced oxidative stress with neuroimmunodegeneration is suppressed by antioxidant treatment with a refined monosodium alpha-luminol (Galavit). J Virol., 80(9):4557-69 (2006).
6. Mates JM, et al., Chemical and biological activity of free radical scavengers in allergic diseases. Clinica Chimica Acta 296, 1-15 (2000).
7. Ostrakhovitch E., Afanas'ev IB., Oxidative stress in rheumatoid arthritis leukocytes : suppression by rutin and other antioxidants and chelators. Biochemical Pharmacology 62:743-746 (2001).
8. Quinn AG., Ultraviolet radiation and skin carcinogenesis. Br J Hasp Med. 17-30;
9. Quinn AG., Ultraviolet radiation and skin carcinogenesis. Br J Hasp Med. 58(6):261-4 (1997).
10. Atabek ME, et al., Protein oxidation in obesity and insulin resistance. Eur J Pediatr. (2006).
11. Khan NI., Naz L., Yasmeen G., Obesity: an independent risk factor for systemic oxidative stress, Pak J Pharm Sci. 19(1):62-5 (2006).
12. Walker LM., et al. Oxidative Stress and Reactive Nitrogen Species Generation during Renal Ischemia, Toxicological Sciences 63, 143-148 (2001).
13. Bledsoe G. et al., Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery, Hum Gene Ther., 17(5):545-55 (2006).
14. McFariane SI., et al., Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? , Endocrine, 23(1):1-10 (2004).
15. Suda N., Morita I., Kuroda T., Murota S., Participation of oxidative stress in the process of osteoclast differentiation, Biochim Biophys Acta, 11;
16. Suda N., Morita I., Kuroda T., Murota S., Participation of oxidative stress in the process of osteoclast differentiation, Biochim Biophys Acta, 1157(3):318-23 (1993).
17. Barber SC., Mead RJ., Shaw PJ., Oxidative stress in ALS : A mechanism of neurodegeneration and a therapeutic target, Biochim Biophys Acta (2006).
18. Castellani RJ., et al., Neuropathology of Alzheimer disease: pathognomonic but not pathogenic, Acta Neuropathol (Berl), 111 (6):503-9 (2006).
19. Schapira AH., Etiology of Parkinson's disease, Neurology, 23;
20. Schapira AH., Etiology of Parkinson's disease, Neurology, 66(10 Suppl 4):S10-23 (2006).
21. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology. (2006).
22. Madamanchi NR., VendrovA., Runge MS., Oxidative stress and vascular disease. Arterioscler Thromb Vase Biol. Jan;
23. Madamanchi NR., VendrovA., Runge MS., Oxidative stress and vascular disease. Arterioscler Thromb Vase Biol. 25(1):29-38 (2005)
24. Julius M, et al., Glutathione and morbidity in a common-based sample of elderly, J Clin Epidemiol., 47(9):1021-6 (1994).
25. Jenner P., Oxidative damage in neurodegenerative disease, Lancet, 344(8925)796-8 (1994).
26. Arnaud J., Favier A., Le zinc in : Les oligo-éléments en medicine et biologie, Lavoisier TEC&DOC Ed, 459-498 (1991).
27. Talwar D., et al., Effect of inflammation on measures of antioxidant status in patients with non-small cell lung cancer, Am J Clin Nutr, 661283-85 (1997).
28. Rock CL., et al., Carotenoids, vitamin A and oestrogen receptor status in breast cancer, Nutrition and Cancer, 25(3):281-96 (1996).
29. Landrum JT., et al., The macular pigment : the effect of 140 days of a lutein supplement, Exp Eye Res, 65:57-62 (1997).
30. Zern TL., Fernandez ML., Cardioprotective effects of dietary polyphenols, J Nutr., 135(10):2291-4(2005)
31. Hertog MG., et al., Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands, Nutition and Cancer, 20(1):21-29 (1993)